These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7705380)

  • 41. Insulin response in relation to insulin sensitivity: an appropriate beta-cell response in black South African women.
    Goedecke JH; Dave JA; Faulenbach MV; Utzschneider KM; Lambert EV; West S; Collins M; Olsson T; Walker BR; Seckl JR; Kahn SE; Levitt NS
    Diabetes Care; 2009 May; 32(5):860-5. PubMed ID: 19196884
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal-model prediction with direct measurements.
    Ader M; Pacini G; Yang YJ; Bergman RN
    Diabetes; 1985 Nov; 34(11):1092-103. PubMed ID: 2864297
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variable effects of the APOC3-482C > T variant on insulin, glucose and triglyceride concentrations in different ethnic groups.
    Waterworth DM; Talmud PJ; Humphries SE; Wicks PD; Sagnella GA; Strazzullo P; Alberti KG; Cook DG; Cappuccio FP
    Diabetologia; 2001 Feb; 44(2):245-8. PubMed ID: 11270684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of norepinephrine on insulin secretion and glucose effectiveness in non-insulin-dependent diabetes.
    Walters JM; Ward GM; Barton J; Arackal R; Boston RC; Best JD; Alford FP
    Metabolism; 1997 Dec; 46(12):1448-53. PubMed ID: 9439541
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.
    Ehrmann DA; Kasza K; Azziz R; Legro RS; Ghazzi MN;
    J Clin Endocrinol Metab; 2005 Jan; 90(1):66-71. PubMed ID: 15507516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism.
    Henriksen JE; Alford F; Handberg A; Vaag A; Ward GM; Kalfas A; Beck-Nielsen H
    J Clin Invest; 1994 Sep; 94(3):1196-204. PubMed ID: 8083360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon?
    Eriksson JW; Smith U; Waagstein F; Wysocki M; Jansson PA
    Diabetes; 1999 Aug; 48(8):1572-8. PubMed ID: 10426375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
    Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.
    Martin BC; Warram JH; Krolewski AS; Bergman RN; Soeldner JS; Kahn CR
    Lancet; 1992 Oct; 340(8825):925-9. PubMed ID: 1357346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes.
    Osei K; Gaillard T; Kaplow J; Bullock M; Schuster D
    Metabolism; 2004 Dec; 53(12):1552-7. PubMed ID: 15562399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.
    Gaillard TR; Schuster DP; Bossetti BM; Green PA; Osei K
    Diabetes Care; 1997 May; 20(5):745-52. PubMed ID: 9135936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determinants of incident non-insulin-dependent diabetes mellitus among blacks and whites in a national sample. The NHANES I Epidemiologic Follow-up Study.
    Lipton RB; Liao Y; Cao G; Cooper RS; McGee D
    Am J Epidemiol; 1993 Nov; 138(10):826-39. PubMed ID: 8237971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity -- a problem that is no longer restricted to minority groups.
    Wiegand S; Maikowski U; Blankenstein O; Biebermann H; Tarnow P; Grüters A
    Eur J Endocrinol; 2004 Aug; 151(2):199-206. PubMed ID: 15296475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests.
    van Haeften TW; Dubbeldam S; Zonderland ML; Erkelens DW
    Diabetes Care; 1998 Feb; 21(2):278-82. PubMed ID: 9539996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Black-white contrasts in insulin levels during pubertal development. The Bogalusa Heart Study.
    Svec F; Nastasi K; Hilton C; Bao W; Srinivasan SR; Berenson GS
    Diabetes; 1992 Mar; 41(3):313-7. PubMed ID: 1551490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ethnic differences in insulin secretion in women at risk of future diabetes.
    Dornhorst A; Chan SP; Gelding SV; Nicholls JS; Baynes C; Elkeles RS; Beard RW; Anyaoku V; Johnston DG
    Diabet Med; 1992 Apr; 9(3):258-62. PubMed ID: 1576808
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors.
    Clausen JO; Borch-Johnsen K; Ibsen H; Bergman RN; Hougaard P; Winther K; Pedersen O
    J Clin Invest; 1996 Sep; 98(5):1195-209. PubMed ID: 8787683
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of superphysiologic hyperinsulinemia on glucose and lipid metabolism in glucose-tolerant offspring of patients with non-insulin-dependent diabetes mellitus (NIDDM).
    Osei K
    Diabetes Res Clin Pract; 1992 Sep; 17(3):169-82. PubMed ID: 1425156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of a sulfonylurea (gliclazide) treatment on insulin sensitivity and glucose-mediated glucose disposal in patients with non-insulin-dependent diabetes mellitus (NIDDM).
    Wajchenberg BL; Santomauro AT; Porrelli RN
    Diabetes Res Clin Pract; 1993 May; 20(2):147-54. PubMed ID: 8375268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced glucose effectiveness as a feature of glucose intolerance: evidence in elderly type-2 diabetic subjects.
    Viviani GL; Pacini G
    Aging (Milano); 1999 Jun; 11(3):169-75. PubMed ID: 10476312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.